GBA1 and cancer: The analysis of GBA1 carriers also yielded statistical significance (χ2 = 9.531, p = 0.0020); however, the estimated effect size was close to zero (95% CI: −6.49% to +5.91%), suggesting that the result reflects heterogeneity rather than a consistent increase or decrease in cancer risk.